NUCLEAR-DELIVERED CONJUGATES
Dead / Abandoned — Abandoned — failure to respond (as of 01 Oct 2020)
What this means for you
This application is over — abandoned 18 Sept 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88730044
- Mark type
- Stylized text
- Filed
- 17 Dec 2019
- Abandoned
- 18 Sept 2020
- Attorney of record
- Susanna P. Lichter
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease
- Class 042 — Scientific and technological services: Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; medical and scientific research for the detection of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease; providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine
Owner
- Angiex, Inc., Cambridge, MA, US
Prosecution history
- 01 Oct 2020 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 01 Oct 2020 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 17 Mar 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Mar 2020 — NON-FINAL ACTION E-MAILED
- 17 Mar 2020 — NON-FINAL ACTION WRITTEN
- 16 Mar 2020 — ASSIGNED TO EXAMINER
- 20 Dec 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Dec 2019 — NEW APPLICATION ENTERED